Document is current
Any future updates will be listed below
-
Authors
Ehrlich, Amy M.
Pacheco, Alline R.
Henrick, Bethany M.
Taft, Diana
Xu, Gege
Huda, M. Nazmul
Mishchuk, Darya
Goodson, Michael L.
Slupsky, Carolyn
Barile, Daniela
Lebrilla, Carlito B.
Stephensen, Charles B.
Mills, David A.
Raybould, Helen E. https://orcid.org/0000-0002-7501-8091
-
Funding
Funding for this research was provided by:
National Institutes of Health (AT006180)
National Institutes of Health (AT007079, AT008759)
Agricultural Research Service (2032-53000-001-00-D)
World Health Organization (2010168947)
- License Information
-
More Information
Article History
Received: 11 May 2020
Accepted: 27 October 2020
First Online: 23 November 2020
Ethics approval and consent to participate
: The data presented here used of 18 fecal samples originally collected as part of a larger trial of Bangladeshi infants (clinicaltrials.gov identifier: NCT01583972). Procedures for recruitment of subjects have been described previously []. Briefly, parents of infants born at the Maternal and Child Health Training Institute in Dhaka, Bangladesh were approached during the third trimester of pregnancy and informed consent was obtained within 48 h of birth. The study was approved by the Ethical Review Committee of the International Centre for Diarrheal Disease Research, Bangladesh (ICDDR,B) and by the Human Studies Committee of the World Health Organization.
: Not applicable.
: DAM, DB and CBL are cofounders of Evolve Biosystems, a company focused on diet-based manipulation of the gut microbiota. Evolve Biosystems played no role in the origination, design, execution, interpretation, or publication of this work.
